CHARGE FOR A CURE - Join Today!
Last Weekend: 3
Season Total: 42
More About Charge for a Cure
January: Parkinson's Disease
February: Breast Cancer
PHILADELPHIA - Now at the halfway point of the 2011 Ivy League season, the University of Pennsylvania women's basketball team has raised more than $3,000 behind the help of 66 donors to the team's Charge for a Cure initiative. Donors have pledged a donation for every offensive charge taken by the Quakers this season with all money raised going toward the fight against five different diseases - ALS, Lupus, Parkinson's, Breast Cancer and Cystic Fibrosis.
The team, which took 34 offensive charges last season, has already accrued 42 charges this year with nine games remaining. Between the 66 donors, every charge taken is now worth approximately $80 toward the cause. Donors have included many members of the Penn Athletics Department, Penn Alumni, current athletes, members of the media and family and friends.
"I think this has been a really great effort by so many people," head coach Mike McLaughlin said of the Charge for a Cure initiative. "The money is extremely helpful to the cause and its a great thing, but even more so is the awareness that this initiative brings toward these diseases. We are grateful to raise money for these causes, but we always felt the most important part of this initiative was about raising awareness. We are getting more donors on a daily basis and we hope this continues to grow so that we have the opportunity to reach as many people as possible."
Please join the women's basketball team as it looks to make a difference in the lives of the people that this disease affects every day. To join the team in Charge for a Cure, contact assistant coach Kara Cassidy at email@example.com. For more information, and a list of organizations the women's basketball program plans on helping this season, click here.
A huge thank you to our donors!!
Sue & Dave Dolan
Mr. & Mrs Dan Rhoads
Guy Van Benschoten
Mr and Mrs Dickson
Chas and Emily
DP Sports Editors
Bill, Jordan and Mark